Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failure

New England Journal of Medicine

Volumn 344, Issue 18, 2001, Pages 1358-1365

  Yancy, Clyde W ^a   Fowler, Michael B ^b   Colucci, Wilson S ^c   Gilbert, Edward M ^d   Bristow, Michael R ^e   Cohn, Jay N ^f   Lukas, Mary Ann ^g   Young, Sarah T ^g   Packer, Milton ^h  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^g GLAXOSMITHKLINE   (United States)

^h The New York Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PLACEBO;

ADULT; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DISEASE CLASSIFICATION; DISEASE EXACERBATION; DRUG EFFECT; FEMALE; FUNCTIONAL ASSESSMENT; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGRO; PRIORITY JOURNAL; RACE DIFFERENCE; RETROSPECTIVE STUDY; SIDE EFFECT;

ADRENERGIC ANTAGONISTS; AFRICAN CONTINENTAL ANCESTRY GROUP; CARBAZOLES; CONTINENTAL POPULATION GROUPS; FEMALE; HEART FAILURE, CONGESTIVE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MORTALITY; PROPANOLAMINES; RETROSPECTIVE STUDIES; STROKE VOLUME; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0035799754     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200105033441803     Document Type: Article

References (39)

1. Racial differences in the outcome of left ventricular dysfunction
2. Racial differences in response to therapy for heart failure: Analysis of the Vasodilator-Heart Failure Trials
3. Racial differences in patients with heart failure
4. Hypertension in minorities: Blacks
5. Racial differences in cardiac structure and function in essential hypertension
6. Influence of race and gender on care process, resource utilization, and hospital-based outcomes in congestive heart failure
7. Trends in hospitalization rates for heart failure in the United States, 1973-1986: Evidence for increasing population prevalence
8. Hospitalization for congestive heart failure: Explaining racial differences
9. Essential hypertension: Racial/ethnic differences in pathophysiology
10. Hypertension in minority populations: Access to care
11. What explains black-white differences in survival in idiopathic dilated cardiomyopathy? The Washington, DC, Dilated Cardiomyopathy Study
12. A comparison of verapamil and propranolol for the initial treatment of hypertension: Racial differences in response
13. Single-drug therapy for hypertension in men: A comparison of six antihypertensive agents with placebo
14. Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction
15. Beta-blocker evaluation of survival trial (BEST)
16. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure
17. Novel mechanisms in the treatment of heart failure: Inhibition of oxygen radicals and apoptosis by carvedilol
18. Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure
19. Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure: The PRECISE Trial
20. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure
21. Safety and efficacy of carvedilol in severe heart failure
22. Racial differences in blood pressure control
23. Blunted blood pressure response to central sympathoinhibition in normotensive blacks: Increased importance of nonsympathetic factors in blood pressure maintenance in blacks
24. The interaction of norepinephrine excretion with blood pressure and race in children
25. Cardiovascular and plasma catecholamine response to static exercise in normotensive blacks and whites
26. Age, race, diagnosis, and sodium effects on the pressor response to infused norepinephrine
27. Responsiveness to alpha- and beta-adrenergic receptor agonists: Effect of race in borderline hypertensive compared to normotensive men
28. Racial differences in epinephrine and beta 2-adrenergic receptors
29. Reduced dietary potassium reversibly enhances vasopressor response to stress in African Americans
30. Monotherapy with labetalol compared with propranolol: Differential effects by race
31. Differential effect of chronic treatment with two beta-blocking agents on insulin sensitivity: The carvedilol-metoprolol study
32. Metabolic and cardiovascular effects of carvedilol and atenolol in non-insulin-dependent diabetes mellitus and hypertension: A randomized, controlled trial
33. Plasma insulin levels and incidence of hypertension in African Americans and whites
34. Importance of the adrenergic nervous system in the support of circulatory function in patients with congestive heart failure
35. The effect of beta adrenergic blockade on patterns of urinary sodium excretion: Studies in normal subjects and in patients with heart disease
36. Sodium sensitivity in normotensive human subjects
37. Renal vasculature in essential hypertension: Racial differences